# Berberine Blood Glucose Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/berberine-blood-glucose-meta-analysis-evidence-review
Category: evidence-review
Summary: Berberine Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are s
Last reviewed: 2026-07-08
Reviewed by: Migaku Evidence Review
# Berberine Blood Glucose Meta-analysis: What the Evidence Says

## Quick Answer

Berberine Blood Glucose Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study | systematic review | 1 | 2026-05-29 | 10.1371/journal.pone.0348907 |
| A Systematic Review of Herbal Medicines in the Management of Diabetes: Efficacy, Toxicological Profiles, and Clinical Safety Considerations | systematic review | 1 | 2026-04-23 | 10.7759/cureus.107618 |

## What The Sources Report

- The disease is associated with substantial morbidity and mortality, primarily due to its long-term complications such as cardiovascular disease, nephropathy, neuropathy, and retinopathy. [Shadin Md. (2026); evidence level 1]
- Beyond health consequences, T2DM imposes a considerable economic burden on healthcare systems and societies, contributing to reduced productivity and increased healthcare expenditures. [Shadin Md. (2026); evidence level 1]
- Prediabetes is defined as an intermediate metabolic state characterized by impaired fasting glucose and/or impaired glucose tolerance, associated with a high risk of progression to diabetes and vascular dysfunction. [Muacevic Alexander (2026); evidence level 1]
- However, long-term use of conventional antidiabetic agents has been associated with adverse effects, reduced tolerance, and diminished efficacy in certain populations. [Muacevic Alexander (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For berberine blood glucose meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Shadin Md. (2026). Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study. DOI: 10.1371/journal.pone.0348907. PMCID: PMC13221027. PMID: 42213651. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13221027/
- Muacevic Alexander (2026). A Systematic Review of Herbal Medicines in the Management of Diabetes: Efficacy, Toxicological Profiles, and Clinical Safety Considerations. DOI: 10.7759/cureus.107618. PMCID: PMC13198626. PMID: 42186642. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13198626/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.